Literature DB >> 12797718

Measuring disease specific quality of life in localized prostate cancer: the Dutch experience.

I J Korfage1, M L Essink-Bot, J B Madalinska, W J Kirkels, M S Litwin, H J de Koning.   

Abstract

OBJECTIVE: We aimed at developing and testing a Dutch health-related quality of life measure for localized prostate cancer patients.
METHODS: Scales on urinary and bowel function and bother from the UCLA Prostate Cancer Index (PCI) underwent formal linguistic and cultural translation. PCI sexual scales were replaced by an existing Dutch sexual activities module (SAc). After qualitative pilot testing 389 patients with localized prostate cancer (mean age 67 +/- 7 years) completed the measure before and at 2 time points after primary treatment. Psychometric properties (feasibility, score distribution, reliability, construct validity and responsiveness to change) of the new instrument were analyzed.
RESULTS: Response rates ranged from 93% at baseline to 87% after treatment. Urinary and bowel function scales showed Cronbach's alphas >0.7. Urinary function and bother, and bowel function and bother were significantly correlated. Pre- vs. post-prostatectomy effect sizes were >0.9 only for urinary scales; while pre- vs. post-radiotherapy effect sizes were >0.75 only for bowel scales. Six months after baseline erectile dysfunction was reported by 64% of respondents, either as a problem in sexual activity or as a reason for not being sexually active.
CONCLUSION: The Dutch PCI and SAc performed well in men treated for early stage prostate cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12797718     DOI: 10.1023/a:1023402706666

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  10 in total

1.  Interpreting SF-36 summary health measures: a response.

Authors:  J E Ware; M Kosinski
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Sexual functioning in patients with localized prostate cancer awaiting treatment.

Authors:  L Incrocci; J B Madalinska; M L Essink-Bot; W L Van Putten; P C Koper; F H Schröder
Journal:  J Sex Marital Ther       Date:  2001 Jul-Sep

3.  The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

Authors:  R C Rosen; A Riley; G Wagner; I H Osterloh; J Kirkpatrick; A Mishra
Journal:  Urology       Date:  1997-06       Impact factor: 2.649

4.  Modeling valuations for EuroQol health states.

Authors:  P Dolan
Journal:  Med Care       Date:  1997-11       Impact factor: 2.983

5.  Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.

Authors:  J B Madalinska; M L Essink-Bot; H J de Koning; W J Kirkels; P J van der Maas; F H Schröder
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

6.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Authors:  J T Wei; R L Dunn; M S Litwin; H M Sandler; M G Sanda
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

7.  Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.

Authors:  Harry J de Koning; Anssi Auvinen; Antonio Berenguer Sanchez; Fernando Calais da Silva; Stefano Ciatto; Louis Denis; John K Gohagan; Matti Hakama; Jonas Hugosson; Ries Kranse; Vera Nelen; Philip C Prorok; Fritz H Schröder
Journal:  Int J Cancer       Date:  2002-01-10       Impact factor: 7.396

8.  Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment.

Authors:  J B Madalinska; M L Essink-Bot; H J de Koning; W J Kirkels; P J van der Maas; F H Schröder
Journal:  Prostate       Date:  2001-02-01       Impact factor: 4.104

9.  Erection problems in medical practice: differential diagnosis with relatively simple method.

Authors:  A K Slob; J H Blom; J J van der Werff ten Bosch
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

10.  The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

Authors:  M S Litwin; R D Hays; A Fink; P A Ganz; B Leake; R H Brook
Journal:  Med Care       Date:  1998-07       Impact factor: 2.983

  10 in total
  6 in total

Review 1.  The effect of ethnicity and sexual preference on prostate-cancer-related quality of life.

Authors:  Nir Kleinmann; Nicholas G Zaorsky; Timothy N Showalter; Leonard G Gomella; Costas D Lallas; Edouard J Trabulsi
Journal:  Nat Rev Urol       Date:  2012-04-10       Impact factor: 14.432

2.  Early assessment of patient satisfaction and health-related quality of life following robot-assisted radical prostatectomy.

Authors:  Eun Yong Choi; Jeongyun Jeong; Dong Il Kang; Kelly Johnson; Thomas Jang; Isaac Yi Kim
Journal:  J Robot Surg       Date:  2010-08-29

Review 3.  Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.

Authors:  Ronald C Chen; Peter Chang; Richard J Vetter; Himansu Lukka; William A Stokes; Martin G Sanda; Deborah Watkins-Bruner; Bryce B Reeve; Howard M Sandler
Journal:  J Natl Cancer Inst       Date:  2014-07-08       Impact factor: 13.506

4.  Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.

Authors:  Stefanie Schmidt; Olatz Garin; Yolanda Pardo; José M Valderas; Jordi Alonso; Pablo Rebollo; Luis Rajmil; Carlos Garcia-Forero; Montse Ferrer
Journal:  Qual Life Res       Date:  2014-04-19       Impact factor: 4.147

Review 5.  Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.

Authors:  Salome Adam; Anita Feller; Sabine Rohrmann; Volker Arndt
Journal:  Health Qual Life Outcomes       Date:  2018-01-23       Impact factor: 3.186

6.  Feasibility and acceptability of follow-up for prostate cancer in primary care: a pilot study.

Authors:  Marianne Heins; François Schellevis; Mirjam Schotman; Bart van Bezooijen; Ismene Tchaoussoglou; Mirjam van der Waart; Lilan Veldhuis; Sandra van Dulmen; Gé Donker; Joke Korevaar
Journal:  BJGP Open       Date:  2018-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.